Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The objective of the current study is to demonstrate bioequivalence of two 2.5 mg
linagliptin/500 mg metformin fixed dose combination tablets compared to the free combination
of the linagliptin 5 mg and metformin 1000 mg in healthy male and female volunteers.